|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue (2025 - $23,921; 2024 - $4,225; 2023 - $16,897 from related party) | |||||
| Cost of sales | |||||
| Gross margin | |||||
| Research and development expenses | |||||
| General and administrative expenses | |||||
| Other expenses (2025 - $0; 2024 - $767; 2023 - $32,875 from related party) | |||||
| Loss from operations | |||||
| Sponsored cost share | |||||
| Change in fair value of warrant liabilities | |||||
| Investment income | |||||
| Loss before income taxes | |||||
| Provision (benefit) for income taxes | |||||
| Foreign income taxes | |||||
| Net loss | |||||
| Net loss attributable to legacy NuScale LLC holders prior to Transaction | |||||
| Net loss attributable to noncontrolling interests | |||||
| Net Loss Attributable to Class A Common Stockholders | |||||
| Loss Per Share of Class A Common Stock: | |||||
| Basic (usd per share) | |||||
| Total basic (usd per share) | |||||
| Diluted (usd per share) | |||||
| Total diluted (usd per share) | |||||
| Weighted-Average Shares of Class A Common Stock Outstanding: | |||||
| Basic (shares) | |||||
| Total basic (shares) | |||||
| Diluted (shares) | |||||
| Total diluted (shares) | |||||
Loading...
